Results 111 to 120 of about 6,803 (197)

Reversión del bloqueo neuromuscular inducido por vecuronio: sugammadex o neostigmina [PDF]

open access: yes, 2014
Introducción: se han descrito diferencias entre la reversión de los bloqueantes neuromusculares con sugammadex y neostigmina. La mayoría concuerda que los resultados con sugammadex son superiores.
Idoris Cordero Escobar   +2 more
core  

Effects of sugammadex and rocuronium mast cell number and degranulation in rat liver

open access: yes, 2012
PubMed: 22827538We investigated the effect of rocuronium- and sugammadex-induced mast cell increase and degranulation in rat portal triads. Forty-two rats, in six groups, received either rocuronium 1 mg.kg -1; sugammadex 15 mg.kg -1; sugammadex 100 mg.kg
Erdivablı, Başar   +6 more
core   +1 more source

Pro: The Use of Sugammadex Does Not Preclude the Need for Objective Neuromuscular Monitoring. [PDF]

open access: yes
Based on strong evidence, optimal management of neuromuscular block should incorporate objective (or quantitative) neuromuscular monitoring with appropriately dosed antagonists such as sugammadex.
Renew, J Ross, Linn, Dustin D
core   +1 more source

Sugammadex

open access: yesSouthern African Journal of Anaesthesia and Analgesia, 2020
There are a large number of publications which describe the use of cyclodextrins (CDs) in numerous fields, including biomedicine, cosmetics, food industry, wastewater remediation and catalysis. These drugs contain a number of glucose monomers in a ring, creating a cone shape: α (alpha), β (beta), and γ (gamma) cyclodextrins with 6, 7 and 8 glucose ...
openaire   +2 more sources

CRNAs and Sugammadex Use: A Qualitative Analysis [PDF]

open access: yes, 2020
Background: The availability of Sugammadex has increased options for Certified Registered Nurse Anesthetists’ (CRNAs) and their choice of neuromuscular reversal agents, however administration is impacted by a variety of provider and institutional factors.
Mancewicz, Emily, BSN, RN   +1 more
core  

Evaluation of the effects of intra-arterial sugammadex and dexmedetomidine: an experimental study

open access: yesRevista Brasileira de Anestesiologia
Background: Intra-arterial injection of medications may cause acute and severe ischemia and result in morbidity and mortality. There is no information in the literature evaluating the arterial endothelial effects of sugammadex and dexmedetomidine.
Volkan Hancı   +9 more
doaj   +1 more source

Sugammadex use in pediatric patients with stage IV-V chronic kidney disease in a quaternary referral hospital: a case series

open access: yesBMC Anesthesiology
Background Sugammadex is a pharmacologic agent that provides rapid reversal of neuromuscular blockade via encapsulation of the neuromuscular blocking agent (NMBA).
Sindhu N. Samba   +5 more
doaj   +1 more source

Recommendations for Sugammadex Administration in Standard and Special Populations [PDF]

open access: yes
The purpose of this project was to collect evidence-based information regarding sugammadex administration in both standard and selected special populations. Special populations included renal failure, breastfeeding, pregnancy, and pediatrics.
Brummund, Alexa, Mattson, Kristen E
core  

Effects of sugammadex on coagulation: a systematic review and meta-analysis

open access: yesBMC Anesthesiology
Background Sugammadex, an innovative agent that rapidly and completely reverses rocuronium-induced neuromuscular blockade, may prolong coagulation time and influence postoperative bleeding.
Yu-Hsun Tsai   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy